Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
This is the first update to the original CTS communication distributed on July 6th. As previously co...